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Key Summary Points
‘‘Combined’’ entropion surgery (lateral
tarsal strip procedure combined with
either everting sutures or Jones retractor
plication) offers good long-term success.
Researchers planning a randomised
control trial should consider excluding
participants at increased risk of death
during the follow-up period, while
clinicians discussing surgical options with
their patients may wish to consider life
expectancy when choosing between
‘‘combined’’ entropion surgery and more
straightforward everting sutures.
Dear Sir,
We read with great interest the recent article by
Nakos et al. that showed the lateral tarsal strip
(LTS) to have superior surgical success rates and
reduction of symptoms than Quickert everting
sutures (ES) in the repair of primary involu-
tional lower eyelid entropion after one year [1].
We wish to complement their findings with
those of our own Yorkshire Entropion Study (not
previously published)—a randomised con-
trolled trial with long-term (12-year) follow-up
in which we attempt to compare two tech-
niques for the surgical correction of involu-
tional entropion.
Nakos et al. discuss the two key causative
factors in primary involutional lower eyelid
entropion (horizontal lid laxity, mainly due to
senile lateral canthal tendon elongation or
dehiscence, and vertical laxity, due to detach-
ment of the inferior retractors from the tarsus)
and have designed a study that evaluates the
comparative success rates of repairs that address
either the horizontal (LTS) or vertical (ES)
component. In the Yorkshire Entropion Study we
have compared two different ‘‘combined’’ pro-
cedures that address both components simul-
taneously—LTS plus ES vs. LTS plus Jones
retractor plication. The primary outcome mea-
sure was success (no need for further surgery) vs.
failure (need for further surgery) at two-year
follow-up, although data collection was possible
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beyond this time point, the results of which are
presented here.
Our study was granted ethical approval by
the Leeds Teaching Hospital NHS Trust research
ethics committee. This study adhered to the
tenets of the Declaration of Helsinki, and
informed consent was obtained from all study
participants. Ninety-nine participants (mean
age = 77 years, range 60–92) were recruited into
the study between October 2006 and December
2007 and randomised into the LTS ? ES group
(n = 53) or the LTS ? Jones group (n = 46). Of
the 99 recruited participants, 26 were removed
because of participant withdrawal or complete
non-attendance of follow-up appointments. We
attempted to obtain 12-year follow-up, and a
further 14 participants were subsequently
removed as their case records were either
destroyed or were not traceable by the time of
the study’s conclusion. Of the remaining 59
participants included in the study, 32 were in
the LTS ? ES group and 27 were in the LTS ?
Jones group. Post-operative follow-up data
beyond three months are available for only 31
participants (16 LTS ? ES, 15 LTS ? Jones).
There were no cases of undercorrection in
either group at first follow-up. Overcorrection
occurred in no participants in the LTS ? ES
group and in one participant (3.7%) in the
LTS ? Jones group. Recurrence of entropion
occurred in no LTS ? Jones participants during
the follow-up period, but did occur in two
patients in the LTS ? ES group (6.3%). The first
underwent LTS ? ES in 2007 and required fur-
ther entropion surgery in 2011 (four years post-
operatively). The second underwent LTS ? ES in
2007 and re-presented with entropion in 2017
(ten years post-operatively) although they have
not opted for further surgery to date.
The main limitation of our study is the large
source of potential bias created by the number
of participants (n = 40) removed from the study.
Furthermore, if we limit our analysis to only the
31 patients with follow-up data beyond
three months the study becomes underpow-
ered, such that comparative analysis would not
achieve statistical significance. Finally, one-year
follow-up is sufficient to compare the efficacy of
two contrasting procedures such as ES vs. LTS,
but is too short to identify the more subtle
differences between more similar procedures
such as LTS ? ES vs. LTS ? Jones, given their
excellent success rates.
We wish to use our randomised trial to
highlight the difficulties of performing studies
that require a longer follow-up period in an
elderly cohort with an increased mortality rate.
Nonetheless, our findings suggest that ‘‘com-
bined’’ entropion surgery (either LTS ? ES or
LTS ? Jones) offers good long-term success.
Researchers planning a randomised control trial
should consider excluding participants at
increased risk of death during the follow-up
period, while clinicians discussing surgical
options with their patients may wish to con-
sider life expectancy when choosing between
‘‘combined’’ entropion surgery and more
straightforward everting sutures.
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